CI Investments Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$168K Buy
+10,000
New +$168K ﹤0.01% 748
2022
Q4
Sell
-26,786
Closed -$216K 1355
2022
Q3
$216K Sell
26,786
-8,691
-24% -$70.1K ﹤0.01% 575
2022
Q2
$267K Sell
35,477
-10,460
-23% -$78.7K ﹤0.01% 555
2022
Q1
$431K Sell
45,937
-7,219
-14% -$67.7K ﹤0.01% 555
2021
Q4
$426K Buy
53,156
+4,708
+10% +$37.7K ﹤0.01% 627
2021
Q3
$472K Sell
48,448
-4,238
-8% -$41.3K ﹤0.01% 611
2021
Q2
$522K Buy
52,686
+10,626
+25% +$105K ﹤0.01% 622
2021
Q1
$485K Buy
42,060
+1,141
+3% +$13.2K ﹤0.01% 560
2020
Q4
$395K Buy
40,919
+10,657
+35% +$103K ﹤0.01% 571
2020
Q3
$273K Buy
30,262
+7,339
+32% +$66.2K ﹤0.01% 521
2020
Q2
$283K Buy
+22,923
New +$283K ﹤0.01% 481
2016
Q4
Sell
-369,900
Closed -$17M 220
2016
Q3
$17M Sell
369,900
-350,700
-49% -$16.1M 0.19% 112
2016
Q2
$36.2M Sell
720,600
-18,500
-3% -$929K 0.41% 71
2016
Q1
$39.5M Sell
739,100
-17,689
-2% -$947K 0.5% 58
2015
Q4
$49.7M Buy
+756,789
New +$49.7M 0.63% 50